Cardiff International (OTCQB:CDIF) said today that it has agreed to acquire MedicaMetrix as a subsidiary in an all-stock transaction valued at $6 million. Delaware-based MedicaMetrix has developed a medical device, ProstaMetric, that enables more effective prostate cancer diagnosis and monitoring. The device won CE Mark clearance in the European Union in October last year and has […]
Urology diagnostics maker MedicaMetrix Inc. landed a $66,950 grant under the Medical Device Development Center’s "fast-lane" program to continue the development of its ProstaGlove for low cost detection of prostate cancer.
The grant was supported by the Massachusetts Technology Collaborative’s John Adams Innovation Institute.